Vaccine Rollout Hits First U.S. Snags With Delays, Allergic Case

December 16, 2020, 9:05 PM UTC

The first known allergic reaction to the Pfizer Inc. Covid-19 vaccine in the U.S. was reported in Alaska as some snarls began to emerge in the effort to send the shots across the country, highlighting the daunting challenges ahead for a historic immunization drive.

A health-care worker in Juneau, Alaska, with no history of allergies experienced flushing and shortness of breath 10 minutes after receiving a shot, the state health department said in a statement Wednesday.

The person was admitted to the emergency room and was given Pepcid, Benadryl and epinephrine through an intravenous drip. The patient stayed overnight and ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.